Poster

Best Practices for Mental Health Treatment Teams From the Perspective of Certified Peer Support Specialists (CPSS): Results of a CPSS Roundtable

Certified Peer Support Specialists (CPSS) are people with lived experience who serve on treatment teams to help guide peers in their recovery process. A CPSS roundtable was convened to as...

LaGenia Bailey , PharmD, BCPP;

10/26/2023

Budget Impact of Aripiprazole Once Every Two Months Long-Acting Injectable for Adult Patients with Bipolar-I Disorder in the US

In this study, a cost-offset analysis was conducted to evaluate the budget impact of introducing a new 2-monthly injectable formulation of aripiprazole in commercial health plans. In a hy...

Vakaramoko Diaby ;

10/26/2023

Budget Impact of Aripiprazole Once Every Two Months Long-Acting Injectable for Adult Patients with Schizophrenia in the US

A cost-offset analysis was conducted to evaluate the budget impact of introducing a new 2-monthly injectable formulation of aripiprazole in commercial health plans. In a hypothetical heal...

Vakaramoko Diaby ;

10/26/2023

Burden of Bipolar I Disorder on Clinical, Economic, and Humanistic Outcomes: Matched Analysis of US National Health and Wellness Survey Data

Patients with bipolar I disorder (BD-I) have an increased risk of obesity. This analysis assessed real-world outcomes in patients with BD-I vs controls using 2016/2020 National Health and...

Hemangi Panchmatia , MSc;

10/26/2023

Adjunctive Brexpiprazole in Patients With Major Depressive Disorder Who Had One Prior Inadequate Antidepressant Including in a Subgroup With Energy/Concentration Symptoms

This post hoc pooled analysis of three randomized, fixed-dose, 6-week studies explored the efficacy of adjunctive brexpiprazole 2–3 mg/day in patients with major depressive disorder who h...

Shivani Kapadia ;

10/26/2023

Association between Anhedonia Severity and Clinical and Humanistic Outcomes Among US Adults with Major Depressive Disorder

This study examined the association of anhedonia severity with health-related outcomes among adults with major depressive disorder (MDD). The results showed that higher anhedonia scores w...

Tiina Drissen , PhD;

10/26/2023

Adjunctive Cariprazine in Patients With Major Depressive Disorder: A Post Hoc Analysis of Efficacy and Safety by Background Antidepressant Therapy

In this post hoc analysis, data from a phase 3 trial were used to evaluate adjunctive cariprazine versus adjunctive placebo by background ADT in patients with MDD and inadequate response ...

Majid Kerolous , PharmD, MPH;

10/26/2023

Agitation Associated with Schizophrenia or Bipolar Disorder: Sublingual Dexmedetomidine Film Efficacy by Baseline Agitation Level

Dexmedetomidine sublingual film reduced agitation symptoms as early as 20 minutes at 180mcg group and 30 minutes at 120mcg, regardless of baseline agitation severity.

Beth Chopp , PhD;

10/26/2023

Alternating Hemi-auto-prosopometamorphopsia (Cerebral Asthenopia) of Kith and Kin Mirror Hallucinations.

Prosopometamorphopsia has been noted to be one of the rare symptoms of schizophrenia. Our patient, with schizoaffective disorder, presented with hemi-autoprosopometamorphopsia with half o...

Shreya Dutt , MBBS;

10/26/2023

An Updated Meta-Analysis of the Clinical Utility of Combinatorial Pharmacogenomic Testing for Adult Patients with Depression

This updated meta-analysis investigating the clinical utility of combinatorial pharmacogenomic testing in adult patients (Nf3,532) with depression found that care guided by access to the ...

Melissa P. Dyer , PhD;

10/26/2023